Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.53 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 4/20 | 0.47 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 3/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.45 |
| ▸ | CTSS | P25774 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | TACR1 | P25103 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14320399 | 1.00 | CTRB1 (0.53) | CTRB1ANPEPMMP2CTSLDPP8 | |
| SCHEMBL12295600 | 0.95 | ANPEP (0.56) | CTRB1ANPEPMMP2CTSLDPP8 | |
| SCHEMBL2266912 | 0.84 | CTRB1 (0.49) | CTRB1ANPEPMMP2CTSLDPP8 | |
| SCHEMBL2266918 | 0.84 | CTRB1 (0.49) | CTRB1ANPEPMMP2CTSLDPP8 | |
| SCHEMBL14320293 | 0.82 | SYK (0.57) | CTSLCTSKSYKCTSBCTSS | |
| SCHEMBL14320294 | 0.82 | SYK (0.57) | CTSLCTSKSYKCTSBCTSS | |
| Hydrochloric Acid SCHEMBL4889200 | 0.81 | ANPEP (0.51) | ANPEPDPP8DPP7DPP4DPP9 | |
| SCHEMBL12294699 | 0.81 | CTRB1 (0.61) | CTRB1CTSLCTSKSYKCTSB | |
| SCHEMBL14643375 | 0.81 | CTRB1 (0.61) | CTRB1CTSLCTSKSYKCTSB | |
| SCHEMBL22574555 | 0.79 | CTRB1 (0.53) | CTRB1CTSLSYKCTSSHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8598123-B2 | Peptide analogues | PFIZER INC. (US) | 2013-12-03 | — | — | US | disclosed |
| US-20120329724-A1 | PEPTIDE ANALOGUES | PFIZER LIMITED | 2012-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120329724-A1 | PEPTIDE ANALOGUES | OPRL1, OGFR, OPRM1 | CTRB1 1862/4885ANPEP 91/4885MMP2 3220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.